Dialysis provider Fresenius Medical Care AG & Co. KGaA announced that it has revised its revenue forecast because of the recent weakening of the Euro against the U.S. dollar.

The company said it now expects revenue to be approximately 1 to 2% below its previous forecast of $13 billion. Net income will be at the low end of its target range of $1.07 billion and $1.09 billion, according to Fresenius, principally due to additional one-time 2011 acquisition costs.